首页> 外文期刊>Bangladesh Journal of Scientific and Industrial Research >Biotransformation of major ginsenoside Rb1 to pharmacologically active ginsenoside Rg3 through fermentation by Weissella hellenica DC06 in newly developed medium
【24h】

Biotransformation of major ginsenoside Rb1 to pharmacologically active ginsenoside Rg3 through fermentation by Weissella hellenica DC06 in newly developed medium

机译:在新开发的培养基中通过Weissella hellenica DC06发酵将主要的人参皂甙Rb1生物转化为具有药理活性的人参皂甙Rg3

获取原文
       

摘要

The study was conducted to develop an edible and low cost growth medium for cultivation of Weissella hellenica DC06, a lactic acid bacteria (LAB) and to study whether, the medium is suitable for bioconversion of major ginsenoside Rb1 into ginsenoside Rg3 through fermentation by W. hellenica DC06. Fourteen different media compositions were investigated to cultivate W. hellenica DC06. Among these, W. hellenica DC06 exhibited the highest growth in media containing 20 g/l radish, 20 g/l glucose, and 10 g/l yeast extract (Medium 3). The optical density of W. hellenica DC06 cultivated in medium 3 reached 1.8 (1.066 x 1010 CFU/ml) after 24 h of incubation. Importantly, the optimized medium was approximately four times cheaper compared to MRS medium. In addition to being economical, the new medium was also edible. Also W. hellenica DC06 showed strong fermentation ability in newly developed medium regarding on major ginsenoside Rb1 biotransformation. Ginsenoside Rb1 was converted into pharmacologically active ginsenoside Rg3 in new medium. In contrast,W. hellenica DC06 showed weak fermentation ability in MRS medium where ginsenoside Rb1 was converted intoginsenoside Rd. The transformation products were analyzed by TLC, and HPLC. Within seven days of fermentation, almost all ginsenoside Rb1 was decomposed and converted into Rg3 in optimized medium. W. hellenica DC06 hydrolyzed two glucose moieties attached to the C-20 position of the ginsenoside Rb1aglyconeand synthesized Rg3 in newly developed medium.Bangladesh J. Sci. Ind. Res. 51(4), 271-278, 2016
机译:进行了这项研究以开发一种可食用的低成本生长培养基,用于培养乳酸菌(LAB)的Weissella hellenica DC06,并研究该培养基是否适合通过W发酵将主要人参皂苷Rb1转化为人参皂苷Rg3。 hellenica DC06。研究了十四种不同的培养基成分,以培养W. hellenica DC06。其中,W。hellenica DC06在含有20 g / l萝卜,20 g / l葡萄糖和10 g / l酵母提取物(培养基3)的培养基中表现出最高的生长。培养24小时后,在培养基3中培养的W. hellenica DC06的光密度达到1.8(1.066 x 1010 CFU / ml)。重要的是,优化培养基比MRS培养基便宜约四倍。除了经济之外,这种新培养基还可以食用。关于主要人参皂苷Rb1的生物转化,W。hellenica DC06在新开发的培养基中也显示出强大的发酵能力。人参皂苷Rb1在新培养基中转化为具有药理活性的人参皂苷Rg3。相反,W。 hellenica DC06在人参皂苷Rb1转化为人参皂苷Rd的MRS培养基中显示出较弱的发酵能力。通过TLC和HPLC分析转化产物。在发酵的7天之内,几乎所有人参皂苷Rb1都被分解并在优化的培养基中转化为Rg3。 W. hellenica DC06水解人参皂苷Rb1aglycone的C-20位置的两个葡萄糖部分,并在新开发的培养基中合成了Rg3。工业界51(4),271-278,2016

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号